In the original version of this article (1), the “Crizotinib” label in Fig. 4F is incorrect; the label should be “Selumetinib”. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets the error.
References
1.
Suzuki
S
, Yonesaka
K
, Teramura
T
, Takehara
T
, Kato
R
, Sakai
H
, et al KRAS inhibitor resistance in MET-amplified KRASG12C non–small cell lung cancer induced by RAS- and non–RAS-mediated cell signaling mechanisms
. Clin Cancer Res
2021
;27
:5697
–707
.©2022 American Association for Cancer Research
2022
American Association for Cancer Research
